Figures & data
![](/cms/asset/92c97cb2-603b-4fce-bd59-6c55cb2ac28f/idrd_a_1458922_uf0001_c.jpg)
Figure 1. Dynamic swelling of Gel/HPMC with increasing concentration of (A) gelatin (B) HPMC (C) glutaraldehyde, gel fraction of Gel/HPMC with increasing concentration of (D) gelatin (E) HPMC (F) glutaraldehyde, porosity of Gel/HPMC with increasing concentration of (G) gelatin (H) HPMC (I) glutaraldehyde, QTP-F released of Gel/HPMC with increasing concentration Of (J) gelatin (K) HPMC (L) glutaraldehyde.
![Figure 1. Dynamic swelling of Gel/HPMC with increasing concentration of (A) gelatin (B) HPMC (C) glutaraldehyde, gel fraction of Gel/HPMC with increasing concentration of (D) gelatin (E) HPMC (F) glutaraldehyde, porosity of Gel/HPMC with increasing concentration of (G) gelatin (H) HPMC (I) glutaraldehyde, QTP-F released of Gel/HPMC with increasing concentration Of (J) gelatin (K) HPMC (L) glutaraldehyde.](/cms/asset/94622ced-ef79-4bd9-8aea-47a598622f2f/idrd_a_1458922_f0001_b.jpg)
Figure 2. (A) 94.38/5.61 of Gel/HPMC and 2% GA (B) 90.56/9.43 of Gel/HPMC and 2% GA (C) 92.90/7.09 of Gel/HPMC and 1.5% GA showing porosity (D) 94.38/5.61 of Gel/HPMC and 2% GA (E) 90.56/9.43 of Gel/HPMC and 2% GA (F) 92.90/7.09 of Gel/HPMC and 1.5% GA showing 3-D structures dynamic swelling at pH 1.2 (G) 94.38/5.61 of Gel/HPMC and 2% GA (H) 90.56/9.43 of Gel/HPMC and 2% GA (I) 92.90/7.09 of Gel/HPMC and 1.5% GA showing 3-D structures dynamic swelling at pH 6.8.
![Figure 2. (A) 94.38/5.61 of Gel/HPMC and 2% GA (B) 90.56/9.43 of Gel/HPMC and 2% GA (C) 92.90/7.09 of Gel/HPMC and 1.5% GA showing porosity (D) 94.38/5.61 of Gel/HPMC and 2% GA (E) 90.56/9.43 of Gel/HPMC and 2% GA (F) 92.90/7.09 of Gel/HPMC and 1.5% GA showing 3-D structures dynamic swelling at pH 1.2 (G) 94.38/5.61 of Gel/HPMC and 2% GA (H) 90.56/9.43 of Gel/HPMC and 2% GA (I) 92.90/7.09 of Gel/HPMC and 1.5% GA showing 3-D structures dynamic swelling at pH 6.8.](/cms/asset/43dca53a-5d79-4497-a6bf-c4b9238a9363/idrd_a_1458922_f0002_c.jpg)
Figure 4. Cumulative % release of QTF-F from Gel/HPMC hydrogels (A) (90.75/9.24) using 2% of GA (B) (92.9/7.09) using 2% of GA (C) (94.38/5.61) using 2% of GA (D) (94.73/5.26) using 2% of GA (E) (93.38/6.61) using 2% of GA (F) (90.56/9.43) using 2% of GA (G) (90.56/9.43) using 1.5% of GA (H) (90.56/9.43) using 3.5% of GA (I) (90.56/9.43) using 4.6% of GA, after 12 hours at pH 1.2 (•), pH 6.8 (▪) and pH 7.4 (▲).
![Figure 4. Cumulative % release of QTF-F from Gel/HPMC hydrogels (A) (90.75/9.24) using 2% of GA (B) (92.9/7.09) using 2% of GA (C) (94.38/5.61) using 2% of GA (D) (94.73/5.26) using 2% of GA (E) (93.38/6.61) using 2% of GA (F) (90.56/9.43) using 2% of GA (G) (90.56/9.43) using 1.5% of GA (H) (90.56/9.43) using 3.5% of GA (I) (90.56/9.43) using 4.6% of GA, after 12 hours at pH 1.2 (•), pH 6.8 (▪) and pH 7.4 (▲).](/cms/asset/4637ba0a-f6aa-4874-b69b-b3adedbf056b/idrd_a_1458922_f0004_b.jpg)
Figure 5. (AA) Synthesis of Gel/HPMC hydrogel (BB) FTIR of (A) Gelatin (B) QTP-F (C) HPMC (D) Unloaded hydrogel (E) Loaded hydrogel (CC) DSC of FTIR of (A) Gelatin (B) QTP-F (C) HPMC (D) Unloaded hydrogel (E) Loaded hydrogel.
![Figure 5. (AA) Synthesis of Gel/HPMC hydrogel (BB) FTIR of (A) Gelatin (B) QTP-F (C) HPMC (D) Unloaded hydrogel (E) Loaded hydrogel (CC) DSC of FTIR of (A) Gelatin (B) QTP-F (C) HPMC (D) Unloaded hydrogel (E) Loaded hydrogel.](/cms/asset/5263ba8e-0a6c-4fc8-b3ef-59a1c66b158e/idrd_a_1458922_f0005_c.jpg)
Figure 6. Sample HPLC chromatogram of QTP-F test hydrogel in plasma (A), Plasma drug concentration (µg/ml) profile of QTP-F test hydrogel in-vivo (B), Sample HPLC chromatogram of QTP-F reference tablet (Qusel®, Hilton Pharma, Karachi, Pakistan) in plasma (C), Plasma drug concentration (µg/ml) profile of QTP-F reference tablet (Qusel®, Hilton Pharma, Karachi, Pakistan).
![Figure 6. Sample HPLC chromatogram of QTP-F test hydrogel in plasma (A), Plasma drug concentration (µg/ml) profile of QTP-F test hydrogel in-vivo (B), Sample HPLC chromatogram of QTP-F reference tablet (Qusel®, Hilton Pharma, Karachi, Pakistan) in plasma (C), Plasma drug concentration (µg/ml) profile of QTP-F reference tablet (Qusel®, Hilton Pharma, Karachi, Pakistan).](/cms/asset/09ff0504-0c14-4411-9b72-075350f04249/idrd_a_1458922_f0006_b.jpg)